Malaria for Health Professionals - Minnesota Dept. of Health

Malaria Information for Health Professionals

The only FDA-approved intravenous (IV) antimalarial medication, quinidine, has been discontinued and will no longer be available. Instead, as of April 1, 2019 IV artesunate is recommended by WHO and CDC to treat patients with severe malaria. Clinicians must call CDC’s Malaria Hotline to obtain the IV artesunate. To access the CDC’s malaria hotline and receive consultations on diagnosis and management of malaria cases on a 24-hour basis, please call 770-488-7788 (from 9 a.m.-5 p.m. ET) or 770-488-7100 (after hours or on weekends and holidays). For detailed information on the criteria for IV artesunate treatment and other frequently asked questions, CDC has posted a Malaria Notice with guidance for hospitals and healthcare providers.

For more information on malaria from the CDC, please visit their website: Malaria Diagnosis & Treatment in the United States.

MDH staff also are available to provide clinical consultation regarding testing and diagnosis of malaria and other mosquito-transmitted diseases. Call 651-201-5414 for a clinical consultation.

See also: Information for Health Care Professionals about Mosquitoborne Diseases
Resources, slides, reporting information and other clinical information for health professionals.

Updated Wednesday, 22-Apr-2020 12:22:18 CDT